EGM
BSX icon

Encore Global Management’s Boston Scientific BSX Stock Holding History

Encore Global Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.15M Buy
73,700
+27,200
+58% +$1.48M 3.09% 13
2026
Q1 		$2.92M Buy
+46,500
New +$3.72M 2.04% 19

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Encore Global Management's BSX Position: Q2 2026 in Review

Encore Global Management increased its Boston Scientific (BSX) stake by 58% in Q2 2026, buying an estimated $1.48M and bringing the position to 73,700 shares worth $3.15M. The position accounts for 3.09% of the portfolio, ranked #13.

Encore Global Management first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Encore Global Management held 73,700 shares of Boston Scientific worth $3.15M as of Q2 2026.
  • Encore Global Management bought 27,200 Boston Scientific shares in Q2 2026, an estimated $1.48M.
  • Boston Scientific made up 3.09% of Encore Global Management's portfolio in Q2 2026, its #13 holding.
  • Encore Global Management first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Encore Global Management's 13F filing for Q2 2026, filed 11 Aug 2026.